Sichuan BiaoXin Pharmaceutical Technology Co., Ltd.

Single and multiple-dose pharmacokinetic studies of Tianhuning for injection were conducted on healthy volunteers to measure the time-dependent blood concentration of the main ingredient Tianhuning, estimate its pharmacokinetic parameters, and determine the pharmacokinetic characteristics of single and multiple-dose injections in healthy male and female volunteers.

To evaluate the efficacy and safety of Tianhuning for injection in the treatment of acute upper respiratory tract infection using Tianhuning for injection/placebo as control.